When we analyzed the immune cells and cytokines between COVID-19 and cancer patients, we discovered that there were similar changes in these biomarkers, such as low lymphocytes, high monocytes, high neutrophils, high IL-6, and high IL-10. This evidence concerns the gene IL6 and COVID-19.